Linda McAllister and Michael Royals of PharmaJet, Inc. in the U.S. will research the mechanisms that make intradermal vaccine delivery more effective than intramuscular vaccines. Understanding how immunizations via the skin work and why reduced doses are needed in this method can enable more cost effective approaches to polio eradication and other global public health problems.
Grant ID
OPP1045862
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False